Autoimmune Disease Diagnostics Market to Grow with a CAGR of 9.03% through 2030

Rising disease prevalence, government initiatives, an expanding product portfolio, and global expansion is expected to drive the Global Autoimmune Disease Diagnostics Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Autoimmune Disease Diagnostics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Autoimmune Disease Diagnostics Market stood at USD 5.74 billion in 2024 and is anticipated to grow with a CAGR of 9.03% in the forecast period through 2030. This can be attributed to collaborations and mergers. Collaboration and mergers within the healthcare sector have also contributed to market growth. Companies often join forces to combine expertise, share resources, and develop more comprehensive diagnostic solutions. These collaborations enable the creation of innovative diagnostics that can address the complexity of autoimmune diseases effectively. Moreover, patient-centric diagnostics prioritize the patient's experience and preferences. This trend emphasizes communication, education, and shared decision-making between patients and healthcare providers. Autoimmune disease diagnostics are evolving to involve patients in the diagnostic process, leading to more informed decisions and improved adherence to treatment plans.

The market is being driven by factors such as the increasing prevalence of autoimmune diseases, heightened awareness regarding disease diagnosis, and advancements in technology. The rising incidence of autoimmune disorders is expected to boost the growth of the autoimmune disease diagnostics market. According to the 2020 Atlas of Multiple Sclerosis Report, over 2.8 million people worldwide, with approximately 1 million in the United States, are currently living with multiple sclerosis. Europe faced a significant burden of autoimmune diseases, with the highest prevalence of multiple sclerosis in 2020, estimated at 2.5 million people globally. Rheumatoid arthritis affects around two million people, and psoriasis, one of the most common autoimmune disorders, is believed to impact between 2% and 3% of the general population. Increased awareness of autoimmune disorders through research, education, support, and advocacy initiatives is a significant driver of rising diagnosis rates.

Furthermore, the escalating global burden of autoimmune diseases, along with increasing health and disease awareness, fuels the demand for early disease detection diagnostics, driving market growth. For example, the American Autoimmune Related Disease Association (AARDA) designates March as Autoimmune Disease Awareness Month (ADAM) to raise awareness and support the eradication of autoimmune diseases. The American Kidney Fund (AKF) launched an educational campaign in February 2021 focused on lupus nephritis, a kidney condition caused by lupus, providing crucial information to patients about symptoms, diagnosis, and treatment. In September 2021, Scipher Medicine partnered with Ventegra Inc. to offer customers access to Scipher's PrismRA liquid molecular signature test, aiding in the personalized treatment of rheumatoid arthritis patients (RA). Despite these promising factors, challenges such as delayed result turnaround, the necessity for multiple diagnostic tests, high costs, reimbursement concerns, and regulatory uncertainties may hinder market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Autoimmune Disease Diagnostics Market.”

Global Autoimmune Disease Diagnostics Market is segmented into component, test type, disease type, end user, regional distribution, and company.

Based on disease type, Systemic Autoimmune Disease Diagnostics is witnessing the fastest growth in the global autoimmune disease diagnostics market. This segment includes complex and multi-organ conditions such as lupus, systemic sclerosis, and Sjögren’s syndrome, which often require a more comprehensive and sensitive diagnostic approach compared to organ-specific diseases. The rising demand for early detection and more accurate disease profiling is one of the primary drivers behind this growth. Systemic autoimmune diseases typically affect multiple body systems, making them harder to diagnose through traditional single-marker tests. As a result, healthcare providers are increasingly turning to advanced diagnostic technologies, such as multiplex immunoassays and autoantibody panels, that can assess multiple biomarkers simultaneously. These tests help in identifying the disease at an earlier stage and enable more targeted and personalized treatment plans.

Based on region, Asia Pacific segment is expected to grow during the forecast period, driven by the increasing incidence of autoimmune diseases and a growing awareness regarding their diagnosis. Furthermore, market players are taking strategic measures, research efforts are on the rise, and healthcare infrastructure is being developed, all of which contribute to the market's growth. According to a June 2022 report from Janssen Asia Pacific, a subsidiary of Johnson & Johnson Pte. Ltd., autoimmune, inflammatory, and respiratory conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease are on the rise in the Asia Pacific region. The area already grapples with the highest global burden of chronic obstructive pulmonary disease (COPD), as well as the highest prevalence of systemic lupus erythematosus (SLE) in China and Southeast Asia. Consequently, there is likely to be an increased demand for diagnostics in the years to come. 

Major companies operating in Global Autoimmune Disease Diagnostics Market are:

• Abbott Laboratories
• Siemens Healthineers AG
• Roche Diagnostics Corp
• Beckman Coulter Inc
• SQI Diagnostics Inc
• EUROIMMUN Medizinische Labordiagnostika AG
• Aesku Diagnostics GmbH & Co KG
• INOVA Diagnostics Inc
• Crescendo Bioscience LLC
• bioMerieux SA

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Autoimmune Disease Diagnostics Market is witnessing a transformation driven by emerging trends that focus on precision medicine, biomarker discovery, point-of-care testing, artificial intelligence, telemedicine, multiplex testing, patient-centric diagnostics, global expansion, and ongoing research and development. These trends hold the promise of improving the accuracy, accessibility, and personalization of autoimmune disease diagnostics, ultimately enhancing patient care and outcomes. As technology continues to advance and the understanding of autoimmune diseases deepens, the future of autoimmune disease diagnostics appears promising, offering hope for better disease management and improved quality of life for patients,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Autoimmune Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Instruments, Reagents, Consumables), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others), By Disease Type (Systemic Autoimmune Disease Diagnostics (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), Localized Autoimmune Disease Diagnostics (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others)), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Autoimmune Disease Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Autoimmune Disease Diagnostics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com